Edit
Biosensors International Group, Ltd
http://www.biosensors.com/Last activity: 29.02.2024
Probably Closed
Biosensors International Group develops, manufactures and commercializes innovative medical devices used in interventional cardiology and critical care procedures. The Company is well positioned to emerge as a leader in drug-eluting stents. It has three separate stent programs, BioMatrix, a drug eluting stent (“DES”) with a bio-degradable polymer, Gazelle, a bare-metal stent, and BioFreedom, a completely polymer-free drug-eluting stent in development. The Company is listed on Singapore Stock Exchange.
Location: Singapore
Investors 2
| Date | Name | Website |
| - | SAIF Partn... | sbaif.com |
| - | Hony Capit... | honycapita... |
Mentions in press and media 5
| Date | Title | Description |
| 09.11.2022 | Huadi International Group Co., Ltd. Announces Closing of $25 Million Registered Direct Offering | - |
| 07.11.2022 | Huadi International Group Co., Ltd. Announces Pricing of $25 Million Registered Direct Offering | - |
| 11.06.2020 | Blue Sail Medical acquires Swiss medtech company NVT AG | The finalization of this deal brings together NVT’s expertise in innovative Transcatheter Aortic Valve Implantation technology, and Biosensors’ solid track record in Interventional Cardiology. |
| 11.06.2020 | Blue Sail Medical acquires Swiss medtech company NVT AG | |
| 18.10.2016 | HK: Good Parents closes $2m seed in round led by Jungle Ventures | Premium Good Parents Inc., a startup launched in October 2015 focused on children’s health and wellness has closed a $2 million seed investment in a round led by senior partners at Singapore’s Jungle Ventures, and with participation from Fi... |